Clinical Trials Directory

Trials / Completed

CompletedNCT02073669

Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults

Better Identification of Latent Tuberculosis Infection Among Israeli Young Adults by Comparison Skin Tests and Interferon Gamma Releasing Assays (IGRA)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

The aim of study is to evaluate the prevalence of latent TB in second generation immigrants from countries with high incidence of tuberculosis (above 20 of 100,000) compare to the control native Israelis without a family member who was born in a country with high incidence of tuberculosis. Using study questionnaire IGRA and tuberculin skin test the investigators expect that the second generation immigrants group will have more positive IGRA test than the control native group.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnswering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)

Timeline

Start date
2014-03-01
Primary completion
2018-08-01
Completion
2018-11-01
First posted
2014-02-27
Last updated
2019-01-25

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT02073669. Inclusion in this directory is not an endorsement.